APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -64.0% | -846.0% | -681.2% | -150.0% | -11.2% | 4.5% | |
| – | – | – | – | – | – | 0.3% | 2.2% | 2.0% | 0.4% | 0.2% | 0.2% | |
| – | – | – | – | – | – | 18.1% | 106.2% | 120.8% | 26.7% | 14.6% | 10.4% | |
| – | – | – | – | – | – | 59.3% | 412.1% | 201.7% | – | – | – | |
| – | – | – | – | – | – | 7.8% | -140.5% | -20.8% | -50.5% | -2.3% | -8.5% | |
| – | – | – | – | – | – | 2.2% | 1.7% | 2.0% | 0.2% | 0.1% | 0.0% | |
| – | – | – | – | – | – | -126.5% | 372.0% | 79.4% | -0.2% | -0.1% | 0.0% | |
| – | – | – | – | – | – | 128.8% | – | – | – | – | – | |
| – | – | – | – | – | – | 0.6% | -2.7% | 5.6% | -2.8% | 0.6% | – | |
| – | – | – | – | – | – | 128.8% | 0.0% | 0.0% | 0.0% | 46.8% | 0.0% | |
| – | – | – | – | – | – | 276.2% | 589.3% | 484.8% | 99.5% | 19.1% | 0.9% | |
| – | – | – | – | – | – | 85.8% | 112.2% | -117.6% | -50.6% | 7.7% | 5.5% | |
| – | – | – | – | – | – | -66.2% | -847.7% | -683.2% | -150.2% | -11.3% | 4.5% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.